Citation: Rc. Labasky et Ap. Spivack, TRANSURETHRAL ALPROSTADIL FOR THE TREATMENT OF ERECTILE DYSFUNCTION -2-YEAR SAFETY UPDATE, The Journal of urology, 159(5), 1998, pp. 907-907
Authors:
WILLIAMS G
ABBOU CC
AMAR ET
DESVAUX P
FLAM TA
LYCKLAMAANIJEHOLT GAB
LYNCH SF
MORGAN RJ
MULLER SC
PORST H
PRYOR JP
RYAN P
WITZSCH UKF
HALL MM
PLACE VA
SPIVACK AP
GESUNDHEIT N
Citation: G. Williams et al., EFFICACY AND SAFETY OF TRANSURETHRAL ALPROSTADIL THERAPY IN MEN WITH ERECTILE DYSFUNCTION, British Journal of Urology, 81(6), 1998, pp. 889-894
Authors:
NORWOOD PC
KAISER FE
NOLTEN WE
SCHALCH DS
PLACE VA
SPIVACK AP
STEPHENS DE
TAM PY
GESUNDHEIT N
Citation: Pc. Norwood et al., TREATMENT OF CHRONIC ERECTILE DYSFUNCTION WITH TRANSURETHRAL ALPROSTADIL IN DIABETIC AND NONDIABETIC MEN, Diabetologia, 40, 1997, pp. 2324-2324
Authors:
KAISER FE
GESUNDHEIT N
HOUSTON KA
JENSEN JM
MORLEY JE
SPIVACK AP
PLACE VA
Citation: Fe. Kaiser et al., NEW TREATMENT FOR ERECTILE DYSFUNCTION (IMPOTENCE) - RESULTS FROM A MULTICENTER TRIAL, Journal of the American Geriatrics Society, 44(9), 1996, pp. 22-22